UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer

The Prostate, 2013-06, Vol.73 (8), p.813-826

2013

Volltextzugriff (PDF)

Direct Raman imaging techniques for study of the subcellular distribution of a drug

Applied Optics, 2002-10, Vol.41 (28), p.6006

2002

Volltextzugriff (PDF)

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues

Cancer research (Chicago, Ill.), 1992-06, Vol.52 (12), p.3396-3401

1992

Volltextzugriff (PDF)

Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis

Cancer research (Chicago, Ill.), 1992-12, Vol.52 (23), p.6708

1992

Volltextzugriff (PDF)

Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives

Journal of community medicine & health education, 2014-04, Vol.4 (3)

Chalela, Patricia

2014

Volltextzugriff (PDF)

Subacute Measles Encephalitis in the Young Immunocompromised Host: Report of Two Cases Diagnosed by Polymerase Chain Reaction and Treated with Ribavirin and Review of the Literature

Clinical infectious diseases, 1993-05, Vol.16 (5), p.654-660

1993

Volltextzugriff (PDF)

Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians

Journal of community medicine & health education, 2012-09

2012

Volltextzugriff (PDF)

Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642)

Investigational new drugs, 2002-08, Vol.20 (3), p.261-270

2002

Volltextzugriff (PDF)

The folate receptor as a potential therapeutic anticancer target

Investigational new drugs, 1998-01, Vol.16 (3), p.205-219

1998

Volltextzugriff (PDF)

A phase 1a / 1b first-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS2612-TPS2612

2018

Volltextzugriff (PDF)

The folate receptor in central nervous system malignancies of childhood

Journal of neuro-oncology, 1994-01, Vol.21 (2), p.107-112

1994

Volltextzugriff (PDF)

Risks and benefits of phase I liver dysfunction studies: Should patients with severe liver dysfunction be included in these trials?

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2536-2536

2014

Volltextzugriff (PDF)

Hepatocellular cancer (HCC) patients on phase I clinical trials in sorafenib era: Analysis of a single institution experience in last 10 years

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15134-e15134

2014

Volltextzugriff (PDF)

Phase 1 cancer clinical trials, evolving by complexity

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e17545-e17545

2015

Volltextzugriff (PDF)

An alvocidib-containing regimen is highly effective in AML patients through a mechanism dependent on MCL1 expression and function

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.7062-7062

2015

Volltextzugriff (PDF)

Predicting success in regulatory approval from phase I results

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.2556-2556

2014

Volltextzugriff (PDF)

Anemia and hepatosplenomegaly as presenting features in a child with rickets and secondary myelofibrosis

Journal of pediatric hematology/oncology, 2003-10, Vol.25 (10), p.813-815

2003

Volltextzugriff (PDF)

A phase 0/1 biomarker and pharmacodynamic study of roflumilast and prednisone in patients with B-cell hematologic malignancies

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e13601-e13601

2015

Volltextzugriff (PDF)

Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study

Journal of pediatric hematology/oncology, 2003-07, Vol.25 (7), p.526-533

2003

Volltextzugriff (PDF)

Overcoming the barriers to early-phase clinical trials (EPCT): Increasing EPCT minority accrual

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e16566-e16566

2012

Volltextzugriff (PDF)

Chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: Are there barriers to ideal care?

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e18046-e18046

2015

Volltextzugriff (PDF)

Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units

Anti-cancer drugs, 1999-10, Vol.10 (9), p.837-844

1999

Volltextzugriff (PDF)

Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units

Anti-cancer drugs, 1999-03, Vol.10 (3), p.309-315

1999

Volltextzugriff (PDF)

Abstract 1721: A steroid-based drug that binds estrogen receptor beta can inhibit cancer cell proliferation by blocking chromosome replication

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1721-1721

2010

Volltextzugriff (PDF)

Comparison of DX-8951f and topotecan effects on tumor colony formation from freshly explanted adult and pediatric human tumor cells

Anti-cancer drugs, 1999-08, Vol.10 (7), p.655-662

1999

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(56)
Bücher
(1)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(36)
Humans
(34)
Oncology
(29)
Biological And Medical Sciences
(24)
Medical Sciences
(23)
Female
(19)
Male
(16)
Pharmacology & Pharmacy
(16)
Pharmacology. Drug Treatments
(15)
Animals
(14)
Antineoplastic Agents
(14)
Child
(12)
Chemotherapy
(11)
Tumor Cells, Cultured
(11)
Adolescent
(10)
Mice
(10)
Child, Preschool
(9)
Pediatrics
(9)
Antineoplastic Agents - Pharmacology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer

Direct Raman imaging techniques for study of the subcellular distribution of a drug

Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues

Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis

Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives

Subacute Measles Encephalitis in the Young Immunocompromised Host: Report of Two Cases Diagnosed by Polymerase Chain Reaction and Treated with Ribavirin and Review of the Literature

Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians

Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642)

The folate receptor as a potential therapeutic anticancer target

A phase 1a / 1b first-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral TP-0903, a potent inhibitor of AXL kinase, administered daily for 21 days to patients with advanced solid tumors

The folate receptor in central nervous system malignancies of childhood

Risks and benefits of phase I liver dysfunction studies: Should patients with severe liver dysfunction be included in these trials?

Hepatocellular cancer (HCC) patients on phase I clinical trials in sorafenib era: Analysis of a single institution experience in last 10 years

Phase 1 cancer clinical trials, evolving by complexity

An alvocidib-containing regimen is highly effective in AML patients through a mechanism dependent on MCL1 expression and function

Predicting success in regulatory approval from phase I results

Anemia and hepatosplenomegaly as presenting features in a child with rickets and secondary myelofibrosis

A phase 0/1 biomarker and pharmacodynamic study of roflumilast and prednisone in patients with B-cell hematologic malignancies

Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study

Overcoming the barriers to early-phase clinical trials (EPCT): Increasing EPCT minority accrual

Chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: Are there barriers to ideal care?

Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units

Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units

Abstract 1721: A steroid-based drug that binds estrogen receptor beta can inhibit cancer cell proliferation by blocking chromosome replication

Comparison of DX-8951f and topotecan effects on tumor colony formation from freshly explanted adult and pediatric human tumor cells

Suchergebnisse filtern